Bridging the Gap When Standard Care Falls Short
Bridging the Gap When Standard Care Falls Short
At TWPHARMA, we believe that every patient deserves a chance, especially when standard treatments have reached their limits. We act as a vital global bridge, connecting Marketing Authorization Holders (MAHs) with physicians and patients to secure access to essential, often life-saving, therapies that are otherwise unavailable through conventional commercial channels.
Our mission is to address critical, unmet medical needs for patients facing serious, life-threatening, or debilitating conditions under the following vital circumstances:
No Approved Local Alternatives: There are currently no regulatory-approved treatment options available for the specific disease within the patient’s home country.
Exhausted Treatment Options: Locally approved therapies exist, but the treating physician has utilized them without clinical success, leaving the patient without further standard options.
Through our dedicated regulatory expertise and ethical supply network, TWPHARMA ensures that hope is never out of reach, turning unmet medical needs into tangible paths toward healing.
Shortages Supply: Ensuring Therapeutic Continuity Amid Global Shortages
A medicine shortage occurs when critical treatments become temporarily unavailable within a national territory, disrupting continuous care and severely impacting patient outcomes. When hospitals and healthcare providers face these critical gaps without local licensed replacements, navigating unlicensed medicine routes to source and import alternatives from other countries becomes a vital necessity.
With global medicine unavailability on the rise, TWPHARMA stands as a dependable partner in times of supply crises. We specialize in sourcing and delivering alternative, high-quality pharmaceuticals from around the world to fill these urgent supply gaps.
By leveraging our robust global network and strict regulatory standards, TWPHARMA guarantees therapeutic continuity for healthcare providers and their patients—ensuring that essential treatments remain accessible when they are needed most.